The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
The p2x7 receptor channel: Recent developments and the use of p2x7 antagonists in models of disease
R Bartlett, L Stokes, R Sluyter - Pharmacological …, 2014 - researchrepository.rmit.edu.au
Abstract glutamic acid prostaglandin proteinase purinergic P2X receptor antagonist
purinergic P2X7 receptor purinergic P2X7 receptor antagonist reactive oxygen metabolite …
purinergic P2X7 receptor purinergic P2X7 receptor antagonist reactive oxygen metabolite …
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
R Bartlett, L Stokes, R Sluyter - 2014 - ro.uow.edu.au
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
[PDF][PDF] The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
EG Efflux, H Phagocytosis - PHARMACOLOGICAL REVIEWS, 2014 - researchgate.net
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
R Bartlett, L Stokes, R Sluyter - Pharmacological reviews, 2014 - pubmed.ncbi.nlm.nih.gov
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
[引用][C] The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
R Bartlett, L Stokes, R Sluyter - Pharmacological Reviews, 2014 - cir.nii.ac.jp
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in
Models of Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Models of Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
[引用][C] The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
R Bartlett, L Stokes, R Sluyter - 2014 - islhd.intersearch.com.au
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.
R Bartlett, L Stokes, R Sluyter - Pharmacological Reviews, 2014 - europepmc.org
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
The p2x7 receptor channel: Recent developments and the use of p2x7 antagonists in models of disease
R Bartlett, L Stokes, R Sluyter - Pharmacological …, 2014 - researchrepository.rmit.edu.au
The p2x7 receptor channel: Recent developments and the use of p2x7 antagonists in models of
disease - RMIT University Logo image Find research works Limit search to: New Search About the …
disease - RMIT University Logo image Find research works Limit search to: New Search About the …